This topic contains a solution. Click here to go to the answer

Author Question: A business marketer who places the highest priority on achieving control in the channel of ... (Read 175 times)

Melani1276

  • Hero Member
  • *****
  • Posts: 516
A business marketer who places the highest priority on achieving control in the channel of distribution should use:
 A) a direct channel.
  B) a channel which includes numerous industrial distributors.
  C) a channel which includes numerous manufacturers' representatives.
  D) a channel which includes numerous commission merchants.
  E) an indirect channel.

Question 2

Concerning the compensation of manufacturers' representatives, the business marketer compensates them on the following basis:
 A) percentage commission.
  B) a salary.
  C) salary plus commission.
  D) varies by product category.
  E) varies by SIC industry.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt95

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

A

Answer to Question 2

A




Melani1276

  • Member
  • Posts: 516
Reply 2 on: Jun 28, 2018
YES! Correct, THANKS for helping me on my review


  • Member
  • Posts:
Reply 3 on: Yesterday
Excellent

 

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library